Imricor (IMR) is held by 2 ASX ETFs. Over the last 3 months it fell 17.4%: on $10,000, −$1737. We explain 3 big moves in that time.
About IMR
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$520.0m
- Held by2 ETFs
- Big moves3 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +3.1%peak +6.7%18 Sep 2026· Regulatory
Imricor Medical Systems rose as investor interest built ahead of an anticipated US regulatory approval, supported by a new securities quotation filing that signals a recent capital raise settling into the market.
- −0.5%peak +2.4%14 Aug 2026· Regulatory
Imricor Medical Systems rose after news it submitted its final 510(k) devices, bringing its full US FDA product platform closer to regulatory clearance.
- +5.1%13 Aug 2026· Contract
Imricor Medical Systems submitted final 510(k) devices, moving its full US FDA product platform closer to commercialization.
Held by 2 ETFs
Of every $10,000 in each fund, how much is in IMR today.
Why did IMR rise 5.1% on 13 Aug 2026?
Imricor
Imricor Medical Systems submitted final 510(k) devices, moving its full US FDA product platform closer to commercialization.
The price move on August 13 aligns with the announcement on the same day that Imricor submitted final 510(k) devices, a key regulatory milestone for US market commercialization. This is a company-specific positive development, not a broad sector move, and no other major news on the date better explains the jump.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
News coverage
What it did to the 2 ETFs holding IMR
On $10,000 in each fund, at the weight it holds today